Stockreport

Albireo Reports Third Quarter 2017 Financial Results

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF — Executing towards planned A4250 Phase 3 PFIC trial —— Decision on potential approval of elobixibat in Japan expected in the first half of 2018 — BOSTON, Nov. 14, 201 [Read more]